Genome company will start testing of latest hormone
Human Genome Sciences Inc. says it will start clinical testing of a long-acting version of human growth hormone midyear. The drug test, recently cleared to proceed by the U.S. Food and Drug
Human Genome Sciences Inc. says it will start clinical testing of a long-acting version of human growth hormone midyear. The drug test, recently cleared to proceed by the U.S. Food and Drug